ArticleBMJ oncology2025

TERT promoter mutations or protein overexpression define an aggressive subset with favourable immunotherapeutic response in advanced urothelial carcinoma.

Kaifeng Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.